Article
Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses
2 Jul 2024
Abstract excerpt
Human norovirus was discovered more than five decades ago and is a widespread cause of outbreaks of acute gastroenteritis. There are no approved vaccines or antivirals currently available. However, norovirus inhibitors, including capsid-specific monoclonal antibodies (Mabs) and nanobodies, have recently shown promising results. Several Mabs and nanobodies were found to inhibit norovirus replication using a human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
